Tag Archives: acad
ACADIA Pharmaceuticals Announces Initiation of New Phase III
ACADIA Pharmaceuticals Announces Initiation of New Phase III Trial with Pimavanserin for Parkinson’s Disease Psychosis ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it has initiated a new Phase III trial designed to evaluate [...]
ACAD featured Phase 3 play
We have added ACADIA Pharmaceuticals Inc. (ACAD): Nasdaq to our featured and our watch list today and ask you to do some research on this company. We just love the pharma tech plays specially the smaller ones as they could have potential for big moves. ACADIA Pharmaceuticals Inc. (ACAD) : Nasdaq ) Currently trading on [...]
